Balaji S. Srinivasan is the co-founder of&nbsp; <a href="">Counsyl</a>, a genomics&nbsp;startup that began in a&nbsp; <a href="">Stanford dorm room</a>&nbsp;and now tests more than 2.5% of&nbsp;all US births. Counsyl won&nbsp;the Wall Street Journal's <a href="">&nbsp;Innovation Award for Medicine</a>, was named one&nbsp;of Scientific American's&nbsp; <a href="">Top 10 World Changing Ideas</a>, raised more than <a href="" title="Link:">$65M in funding</a> from Peter T <b></b> <b></b> <b></b> <b></b> <b></b> <b></b> <b></b> <b></b> <b></b>hiel's Founders Fund among others, and has become one&nbsp;of the largest clinical g <b></b> <b></b> <b></b> <b></b> <b></b> <b></b>enome centers in the world.&nbsp;Prior to co-founding Counsyl, Dr. Srinivasan taught data mining,&nbsp;statistics, and computational biology in the Department of Statistics&nbsp;at Stanford University. He holds a BS, MS, and PhD in Electrical&nbsp;Engineering and an MS in Chemical Engineering from Stanford. He was&nbsp;an NDSEG, NSF, and VIGRE fellow and has been published in the New&nbsp;England Journal of Medicine, Nature Biotechnology, and Nature Reviews&nbsp;Genetics. <br>



Startup Engineering